✦ LIBER ✦

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Scribed by Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel

Book ID: 117280215
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 124 KB
Volume: 359
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)08089-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ L.H. Lindholm; H. Ibsen; B. Dahof 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; U 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 110 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ B. Dahlof; B.R. Devereux; S.E. Kjeldsen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

The Effect of Losartan Versus Atenolol o

The Effect of Losartan Versus Atenolol on Cardiovascular Morbidity and Mortality in Patients With Hypertension Taking Aspirin: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

✍ Eigil Fossum; Andreas Moan; Sverre E. Kjeldsen; Richard B. Devereux; Stevo Juliu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Regression of hypertensive left ventricu

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

✍ R.B. Devereux; B. Dahlof; E. Gerdts 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Effects of losartan on cardiovascular mo

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB